From: Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia
 | KFRE equations | AUC (95% CI) | NRIa (95% CI) |
---|---|---|---|
5-year risk | |||
 Existing KFRE equations | Original KFRE [17] | 0.94 (0.93–0.95) | 0.19% (0.12–0.30%) |
Original KFRE calibrated for north American [17] | 0.94 (0.93–0.95) | 0.19% (0.12–0.30%) | |
Original KFRE calibrated for non-north American [17] | 0.94 (0.93–0.95) | 0.21% (0.12–0.30%) | |
Pooled KFRE [17] | 0.94 (0.93–0.95) | −0.11% (− 0.20%--0.06%) | |
 Recalibrated KFRE equations | Recalibrated Original KFRE SEA 1b | 0.94 (0.93–0.95) | 0.21% (0.14–0.32%) |
Recalibrated Original KFRE SEA 2c | 0.94 (0.93–0.95) | 1.72% (1.48–1.99%) | |
Recalibrated Pooled KFRE SEAd | 0.94 (0.93–0.95) | – | |
2-year risk | |||
 Existing KFRE equations | Original KFRE [17] | 0.96 (0.95–0.97) | 0.03% (0.01–0.09%) |
Original KFRE calibrated for north American [17] | 0.96 (0.95–0.97) | 0.01% (0–0.06%) | |
Original KFRE calibrated for non-north American [17] | 0.96 (0.95–0.97) | 0.01% (0–0.06%) | |
Pooled KFRE [17] | 0.96 (0.95–0.97) | 0.01% (0–0.06%) | |
 Recalibrated KFRE equations | Recalibrated Original KFRE SEA 1e | 0.96 (0.95–0.97) | 0.31% (0.22–0.44%) |
Recalibrated Original KFRE SEA 2f | 0.96 (0.95–0.97) | −0.23% (− 0.35%--0.15%) | |
Recalibrated Pooled KFRE SEAg | 0.96 (0.95–0.97) | – |